Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by muscle weakness and fatigue, typically resulting from antibodies targeting the acetylcholine receptors (AChR) at the neuromuscular junction. Treatment of MG primarily involves the use of medications aimed at improving neuromuscular transmission and reducing symptoms. Here’s a detailed note covering the …